Reata Receives Orphan Drug Designation for Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease Read more
Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site Read more
FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes Read more
FDA approves first treatment for episodic cluster headache that reduces the frequency of attacks Read more